Mitchell Austin Rudy Purchases 7,500 Shares of Bonk (NASDAQ:BNKK) Stock

Bonk, Inc. (NASDAQ:BNKKGet Free Report) Director Mitchell Austin Rudy acquired 7,500 shares of the firm’s stock in a transaction dated Monday, June 22nd. The stock was bought at an average cost of $1.56 per share, for a total transaction of $11,700.00. Following the purchase, the director directly owned 73,341 shares of the company’s stock, valued at approximately $114,411.96. This trade represents a 11.39% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Mitchell Austin Rudy also recently made the following trade(s):

  • On Tuesday, June 16th, Mitchell Austin Rudy acquired 2,500 shares of Bonk stock. The shares were bought at an average price of $1.32 per share, with a total value of $3,300.00.
  • On Wednesday, June 10th, Mitchell Austin Rudy bought 12,000 shares of Bonk stock. The stock was purchased at an average cost of $1.37 per share, with a total value of $16,440.00.
  • On Thursday, April 9th, Mitchell Austin Rudy bought 31,055 shares of Bonk stock. The shares were purchased at an average price of $2.82 per share, for a total transaction of $87,575.10.

Bonk Trading Up 1.3%

NASDAQ BNKK opened at $1.56 on Thursday. Bonk, Inc. has a 12 month low of $1.25 and a 12 month high of $46.90. The stock has a market cap of $12.48 million, a price-to-earnings ratio of -0.34 and a beta of 1.85. The company’s 50 day moving average is $2.09 and its two-hundred day moving average is $2.99.

Bonk (NASDAQ:BNKKGet Free Report) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share for the quarter. The firm had revenue of $0.79 million during the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.

Hedge Funds Weigh In On Bonk

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BNKK. State Street Corp bought a new stake in Bonk in the 4th quarter worth approximately $33,000. Steward Partners Investment Advisory LLC purchased a new stake in shares of Bonk during the 4th quarter worth approximately $37,000. Jane Street Group LLC bought a new position in shares of Bonk during the 4th quarter valued at approximately $96,000. Finally, Geode Capital Management LLC bought a new position in shares of Bonk during the 4th quarter valued at approximately $128,000. 12.55% of the stock is owned by institutional investors.

Analysts Set New Price Targets

BNKK has been the subject of several recent analyst reports. Wall Street Zen downgraded shares of Bonk from a “hold” rating to a “sell” rating in a report on Sunday. Weiss Ratings cut Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Bonk has an average rating of “Sell”.

Check Out Our Latest Research Report on Bonk

Bonk Company Profile

(Get Free Report)

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.

See Also

Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.